Mata; Nathan L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mata; Nathan L..The latest application filed is for "prophylaxis of skin cancer with retinamides".

Company Profile

0.5.15

Mata; Nathan L. - La Jolla CA US
Mata; Nathan L. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for treating ophthalmic conditions with retinyl derivatives Grant 8,410,168 - Widder , et al. April 2, 2	2013-04-02
Prophylaxis Of Skin Cancer With Retinamides App 20130012591 - Butler; Barry Scott ; et al.	2013-01-10
Methods, Assays And Compositions For Treating Retinol-related Diseases App 20120309835 - Widder; Kenneth ; et al.	2012-12-06
Methods and compositions for treating ophthalmic conditions with retinyl derivatives Grant 8,314,152 - Widder , et al. November 20, 2	2012-11-20
Methods And Compositions For Treating Ophthalmic Conditions Via Serum Retinol, Serum Retinol Binding Protein (rbp), And/or Serum Retinol-rbp Modulation App 20120288568 - Widder; Kenneth ; et al.	2012-11-15
Modulators Of Retinol-retinol Binding Protein (rbp)-transthyretin (ttr) Complex Formation App 20120238632 - Mata; Nathan L. ; et al.	2012-09-20
Methods And Compositions For Treating Ophthalmic Conditions App 20120108665 - Mata; Nathan L. ; et al.	2012-05-03
Methods And Compositions For Treating Opthalmic Conditions With Retinol Derivatives App 20110294891 - Widder; Kenneth ; et al.	2011-12-01
Methods and compounds for treating retinol-related diseases Grant 7,973,079 - Mata , et al. July 5, 2	2011-07-05
Methods And Compositions For Treating Ophthalmic Conditions With Retinyl Derivatives App 20100298443 - WIDDER; Kenneth ; et al.	2010-11-25
Modulators Of Ocular Oxidative Stress App 20090253745 - MATA; Nathan L. ; et al.	2009-10-08
Methods And Compositions For Treating Ophthalmic Conditions Via Modulation Of Megalin Activity App 20090098145 - MATA; Nathan L. ; et al.	2009-04-16
Methods And Compounds For Treating Retinol-related Diseases App 20090088435 - MATA; Nathan L. ; et al.	2009-04-02
Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation App 20090054532 - Mata; Nathan L. ; et al.	2009-02-26
Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation Grant 7,432,307 - Mata , et al. October 7, 2	2008-10-07
Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation App 20070015827 - Widder; Kenneth ; et al.	2007-01-18
Methods and compositions for treating ophthalmic conditions with retinyl derivatives App 20060167088 - Widder; Kenneth ; et al.	2006-07-27
Detection and analysis of ophthalmically-relevant fluorescent molecules App 20060099714 - Mata; Nathan L. ; et al.	2006-05-11
Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation App 20060094063 - Mata; Nathan L. ; et al.	2006-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.